The expert panel proposed adopting the more precise term Invasive Disease Free Survival (IDFS) as a composite end point in early-stage ... ... <看更多>
「invasive disease-free survival」的推薦目錄：
invasive disease-free survival 在 臨床藥學大觀園 - 一週全球藥聞 的相關結果
以無侵襲性疾病存活(invasive disease-free survival，iDFS) 來評估療效，iDFS定義為自隨機分配至復發或死亡的時間。結果發現，2年後neratinib組iDFS顯著優於安慰劑 ... ... <看更多>
invasive disease-free survival 在 Disease Free Survival - an overview | ScienceDirect Topics 的相關結果
Disease -free survival (DFS) is defined as the time from randomization to recurrence of tumor or death, and it is typically used in the adjuvant treatment ... ... <看更多>
invasive disease-free survival 在 Disease-free survival as a surrogate for overall ... - PubMed 的相關結果
Disease -free survival as a surrogate for overall survival in patients with HER2-positive, early breast cancer in trials of adjuvant trastuzumab ... ... <看更多>
invasive disease-free survival 在 Clinical Trial: NCT02414646 - Breast Cancer 的相關結果
Invasive disease -free survival (IDFS), defined as occurrence of any of the following: ipsilateral invasive breast cancer recurrence, regional invasive breast ... ... <看更多>
invasive disease-free survival 在 Disease-free Survival and Invasive-Disease-free Survival in ... 的相關結果
Disease -free Survival and Invasive-Disease-free Survival in the Intention-to-Treat Population. Panel A shows the proportion of patients who were alive ... ... <看更多>
invasive disease-free survival 在 Guidelines for time-to-event end point definitions in breast ... 的相關結果
Using surrogate end points for overall survival, such as disease-free survival, ... BCSS, breast cancer-specific survival; iDFS, invasive disease-free ... ... <看更多>
invasive disease-free survival 在 6-year absolute invasive disease-free survival (IDFS) benefit ... 的相關結果
Abstract PS10-01: 6-year absolute invasive disease-free survival (IDFS) benefit of adding adjuvant pertuzumab to trastuzumab and chemotherapy ... ... <看更多>
invasive disease-free survival 在 T-DM1 doubles HER2-positive invasive disease-free survival 的相關結果
The 3-year invasive disease-free survival rate for 743 patients treated with T-DMI 1 was 88.3%, compared with 77% for 743 patients treated with ... ... <看更多>
invasive disease-free survival 在 Lynparza crosses superiority boundary for invasive disease ... 的相關結果
... the IDMC concluded that the trial crossed the superiority boundary for its primary endpoint of invasive disease-free survival (iDFS) and ... ... <看更多>
invasive disease-free survival 在 Predicting Invasive Disease-Free Survival for ... - IEEE Xplore 的相關結果
An alternative prognosis model framework to predict Invasive Disease-Free Survival (iDFS) for early-stage breast cancer patients, called MP4Ei, is proposed. ... <看更多>
invasive disease-free survival 在 Abemaciclib Plus Adjuvant Endocrine Therapy for High-Risk ... 的相關結果
28 Primary Outcome Analysis of Invasive Disease-Free Survival for monarchE: Abemaciclib Plus Adjuvant Endocrine Therapy for High-Risk Early ... ... <看更多>
invasive disease-free survival 在 Trastuzumab Emtansine for Residual Invasive HER2-Positive ... 的相關結果
The primary end point was invasive disease–free survival (defined as freedom from ipsilateral invasive breast tumor recurrence, ... ... <看更多>
invasive disease-free survival 在 Breast Cancer | JAMA Oncology 的相關結果
Association of Event-Free and Distant Recurrence–Free Survival With ... defined as the absence of invasive disease in breast and axillary ... ... <看更多>
invasive disease-free survival 在 Addition of Abemaciclib to Endocrine Therapy Improves ... 的相關結果
Most invasive disease–free survival events were distant recurrences, observed in 87 patients in the abemaciclib group vs 138 in the control ... ... <看更多>
invasive disease-free survival 在 Significant Interaction Between a Chemotherapy Benefit 的相關結果
... Menopausal Status Found in Terms of Invasive Disease–Free Survival ... with no chemotherapy benefit (hazard ratio for invasive disease ... ... <看更多>
invasive disease-free survival 在 Invasive Disease-Free Survival Improves With Perjeta Plus ... 的相關結果
Adding Perjeta (pertuzumab) to chemotherapy and trastuzumab did not significantly improve overall survival (OS) in women with HER2-positive ... ... <看更多>
invasive disease-free survival 在 Abemaciclib plus Endocrine Therapy Offers Invasive Disease ... 的相關結果
Abemaciclib plus Endocrine Therapy Offers Invasive Disease–Free Survival Benefit in Patients with High-Risk, HR-Positive, Early-Stage Breast Cancer. ... <看更多>
invasive disease-free survival 在 6 versus 12 months of adjuvant trastuzumab for HER2-positive ... 的相關結果
The primary endpoint was disease-free survival, which was calculated from the date of diagnostic biopsy to the date of first invasive breast ... ... <看更多>
invasive disease-free survival 在 Olaparib Prolongs Invasive Disease-Free Survival in BRCA ... 的相關結果
Patients with BRCA-mutated high-risk HER2-negative early breast cancer demonstrated a superior invasive disease-free survival when compared ... ... <看更多>
invasive disease-free survival 在 LYNPARZA® (olaparib) Reduced the Risk of Invasive ... - Merck 的相關結果
First Medicine Specifically Targeting BRCA Mutations to Demonstrate Statistically Significant Improvement in Invasive Disease-Free Survival in Adjuvant ... ... <看更多>
invasive disease-free survival 在 primary outcome analysis of invasive disease-free - World ... 的相關結果
PRIMARY OUTCOME ANALYSIS OF INVASIVE DISEASE-FREE. SURVIVAL FOR monarchE: ABEMACICLIB PLUS ADJUVANT. ENDOCRINE THERAPY FOR HIGH-RISK EARLY ... ... <看更多>
invasive disease-free survival 在 Study: Kadcyla improved invasive disease-free survival - CAP ... 的相關結果
... showing Kadcyla (trastuzumab emtansine) as a single agent significantly reduced the risk of disease recurrence or death (invasive disease-free survival) ... ... <看更多>
invasive disease-free survival 在 a piecewise approach to the extrapolation of invasive disease ... 的相關結果
In adjuvant breast cancer, risk of recurrence is high immediately ... a log-logistic extrapolation is fitted to invasive disease-free survival (IDFS) data ... ... <看更多>
invasive disease-free survival 在 Selection and administration of adjuvant chemotherapy for ... 的相關結果
It is a heterogeneous, phenotypically diverse disease composed of several ... in regards to four-year invasive disease-free survival (DFS, ... ... <看更多>
invasive disease-free survival 在 Disease-Free Survival and the KATHERINE Study - Pharmacy ... 的相關結果
Jacob Kettle, PharmD, BCOP: What are your thoughts on invasive disease-free survival as an end point and its limitations? ... <看更多>
invasive disease-free survival 在 PENELOPE-B Trial of IBRANCE® (palbociclib) in Early Breast ... 的相關結果
... the primary endpoint of improved invasive disease-free survival (iDFS) in ... invasive disease after completing neoadjuvant chemotherapy. ... <看更多>
invasive disease-free survival 在 What is Breast Cancer | Breast Cancer Glossary | NBCC 的相關結果
... will become invasive. Also called ductal carcinoma in situ and intraductal carcinoma. Disease free survival (also referred to as event-free survival) ... <看更多>
invasive disease-free survival 在 Combination of abemaciclib and adjuvant hormone therapy ... 的相關結果
Combination of abemaciclib and adjuvant hormone therapy increases invasive disease-free survival in high-risk early breast cancer RH + HER2-. ... <看更多>
invasive disease-free survival 在 IDMC has concluded that OlympiA trial of Lynparza crossed ... 的相關結果
... crossed superiority boundary for invasive disease-free survival ... are at risk of this disease and explore the potential of Lynparza to ... ... <看更多>
invasive disease-free survival 在 Progression-free survival - Wikipedia 的相關結果
Progression-free survival (PFS) is "the length of time during and after the treatment of a disease, such as cancer, that a patient lives with the disease ... ... <看更多>
invasive disease-free survival 在 Ultrasound-Based Radiomics Analysis for Predicting Disease ... 的相關結果
Here, we developed a radiomics signature based on preoperative US to predict disease-free survival (DFS) in patients with invasive breast ... ... <看更多>
invasive disease-free survival 在 The ExteNET phase III randomized placebo-controlled trial. 的相關結果
Invasive disease -free survival benefit following neratinib as extended adjuvant therapy in centrally-confirmed HER2+ early-stage breast cancer: The ExteNET ... ... <看更多>
invasive disease-free survival 在 OlympiA trial crossed superiority boundary for invasive ... 的相關結果
IDMC has concluded that OlympiA trial crossed superiority boundary for invasive disease-free survival vs. placebo at planned interim ... ... <看更多>
invasive disease-free survival 在 ClinicalTrials.gov Identifier: NCT01772472 的相關結果
Invasive Disease -free Survival Including Second Primary Non-breast Cancer [ Time ... Disease-free survival was defined as the time between randomization and ... ... <看更多>
invasive disease-free survival 在 ESMO 2020: Abemaciclib Improves Invasive Disease-Free ... 的相關結果
ESMO 2020: Abemaciclib Improves Invasive Disease-Free Survival and Reduces Risk of Metastasis in High-Risk Hormone Receptor-Positive, HER2- ... ... <看更多>
invasive disease-free survival 在 S7 Fig. Impact of PIK3CA mutations on the invasive disease ... 的相關結果
Impact of PIK3CA mutations on the invasive disease-free survival (iDFS) and overall survival (OS) of 240 Ki67 high breast cancer patients with stage I-III ... ... <看更多>
invasive disease-free survival 在 T-Dm1 protects against invasive disease E CH EL ON-2 - Nature 的相關結果
invasive primary breast cancer with residual disease ... The primary end point was invasive disease-free ... in overall survival were observed at this time. ... <看更多>
invasive disease-free survival 在 Adjuvant chemotherapy may potentially be avoided in breast ... 的相關結果
1. For postmenopausal women, invasive disease-free survival and distant relapse-free survival was similar between chemoendocrine therapy and ... ... <看更多>
invasive disease-free survival 在 Outcome after invasive recurrence in patients with ductal ... 的相關結果
Distant disease-free survival. Probability of remaining free of distant disease in DCIS patients with invasive local recurrence. DCIS ductal carcinoma in situ. ... <看更多>
invasive disease-free survival 在 IDMC has Concluded that OlympiA Trial of LYNPARZA ... 的相關結果
IDMC has Concluded that OlympiA Trial of LYNPARZA® (olaparib) Crossed Superiority Boundary for Invasive Disease-free Survival Vs. Placebo at ... ... <看更多>
invasive disease-free survival 在 ESMO: Abemaciclib improves invasive disease-free survival in ... 的相關結果
ESMO: Abemaciclib improves invasive disease-free survival in high-risk early breast cancer. Sep 24, 2020. While many patients with hormone receptor ... ... <看更多>
invasive disease-free survival 在 BEATRICE study, adjuvant bevacizumab did not improve ... 的相關結果
... invasive disease-free survival in triple-negative breast cancer ... in invasive disease-free survival compared with patients treated ... ... <看更多>
invasive disease-free survival 在 Recurrence-free survival prediction nomogram bladder cancer 的相關結果
Identifying the prognostic role of preoperative CONUT score on posttreatment recurrence-free survival in primary non-muscle-invasive bladder ... ... <看更多>
invasive disease-free survival 在 Addition of 1-Year Palbociclib to Endocrine Therapy Fails to ... 的相關結果
The addition of 1 year of palbociclib (Ibrance) to endocrine therapy failed to improve invasive disease-free survival (iDFS) in patients ... ... <看更多>
invasive disease-free survival 在 Merck and AstraZeneca's Lynparza lowers breast cancer ... 的相關結果
Lynparza offered statistically significant progress in invasive disease-free survival in the adjuvant treatment of breast cancer. ... <看更多>
invasive disease-free survival 在 APHINITY Press Release 2 March 2017 - Breast International ... 的相關結果
Perjeta plus Herceptin and chemotherapy showed a statistically significant improvement in invasive disease-free survival (iDFS) for people ... ... <看更多>
invasive disease-free survival 在 Invasive Disease-Free Survival 的相關結果
Acronym, Definition. IDFS, Invasive Disease-Free Survival. IDFS, Integrated Definitive Feasibility Study (Gladstone Pacific Nickel, Ltd.; Australia). ... <看更多>
invasive disease-free survival 在 Diffusion-weighted Imaging of Invasive Breast Cancer 的相關結果
... metastasis–free survival in women with invasive breast cancer. ... the tumor (5) were associated with poorer disease-free survival. ... <看更多>
invasive disease-free survival 在 T-DM1 Reduces Residual Invasive Disease in Patients with ... 的相關結果
In this study, T-DM1 reduced the 3-year rate of invasive disease–free survival by 11% compared with trastuzumab. The rate of 3-year survival without ... ... <看更多>
invasive disease-free survival 在 Interleukin-13 receptor alpha 2 expression in tumor cells is ... 的相關結果
... disease-free survival in patients with luminal subtype invasive ... we studied IL-13Rα1 expression in tumor cells of invasive breast ... ... <看更多>
invasive disease-free survival 在 LYNPARZA® (olaparib) Reduced the Risk of ... - Yahoo Finance 的相關結果
First Medicine Specifically Targeting BRCA Mutations to Demonstrate Statistically Significant Improvement in Invasive Disease-Free Survival ... ... <看更多>
invasive disease-free survival 在 Verzenio® (abemaciclib) Significantly Reduced the Risk of ... 的相關結果
The primary objective is invasive disease-free survival, which in ... HER2- invasive early breast cancer with either ≥4 pathologically ... ... <看更多>
invasive disease-free survival 在 ICARE Social Media Post February 2021 - Inherited Cancer ... 的相關結果
Olaparib and Invasive Disease-Free Survival in Patients with BRCA, High-Risk, Early Breast Cancer. By admin in Newsletter Articles & Posts. ... <看更多>
invasive disease-free survival 在 Disease-Free Survival at 2 or 3 Years Correlates With 5-Year ... 的相關結果
Purpose: The conventional primary end point in trials of perioperative systemic therapy for muscle invasive bladder cancer is 5-year overall ... ... <看更多>
invasive disease-free survival 在 Breast Cancer 的相關結果
h Patients found to have invasive disease at total mastectomy or re-excision ... disease-free survival of 94.4% when treated with endocrine ... ... <看更多>
invasive disease-free survival 在 Does NAB-Paclitaxel Increase Invasive Disease-Free Survival ... 的相關結果
Quiz: Does NAB-Paclitaxel Increase Invasive Disease-Free Survival in Early Breast Cancer? 07/16/2019. Copied to clipboard ... ... <看更多>
invasive disease-free survival 在 Clinical Trial Endpoints for the Approval of Cancer Drugs and ... 的相關結果
Improvement in disease-free survival (DFS) has supported drug approval in selected adjuvant settings, in which a large proportion of patients were expected ... ... <看更多>
invasive disease-free survival 在 Opdivo (nivolumab) Significantly Improves Disease Free ... 的相關結果
Opdivo (nivolumab) Significantly Improves Disease Free-Survival vs. Placebo as Adjuvant Therapy for Patients with High-Risk, Muscle-Invasive ... ... <看更多>
invasive disease-free survival 在 Tumor-Infiltrating Lymphocyte Volume Is a Better Predictor of ... 的相關結果
TILV was significantly correlated with disease-free survival in both invasive ductal carcinoma (P = .03) and all subtypes of invasive breast ... ... <看更多>
invasive disease-free survival 在 Press Releases | Friday, May 3, 2019 - Genentech 的相關結果
Approval based on data showing Kadcyla cut the risk of disease recurring by half compared to ... Invasive disease-free survival (iDFS). ... <看更多>
invasive disease-free survival 在 T-DM1 Benefits 'Striking' in HER2+ Early Breast Cancer 的相關結果
Invasive disease -free survival was significantly higher in the T-DM1 group than in the trastuzumab group (hazard ratio for invasive disease or ... ... <看更多>
invasive disease-free survival 在 Use of a Log-Normal Survival Model - TSpace 的相關結果
Background: Invasive breast cancer is a frequently diagnosed disease that now comes ... Key Words: Breast cancer—Disease-free survival—Prognostic factors. ... <看更多>
invasive disease-free survival 在 Surrogate endpoints in oncology: when are they acceptable ... 的相關結果
The adjuvant trial of pertuzumab has now been reported, and showed a miniscule improvement in invasive disease-free survival –another ... ... <看更多>
invasive disease-free survival 在 AstraZeneca and MSD's Lynparza crosses superiority ... 的相關結果
AstraZeneca and MSD's Lynparza crosses superiority boundary for invasive disease-free survival. Published on 17/02/21 at 10:22am. ... <看更多>
invasive disease-free survival 在 Roche provides an update on Phase III study of Tecentriq in ... 的相關結果
... its primary endpoint of disease-free survival (DFS) compared to observation in people with muscle-invasive urothelial cancer (MIUC). ... <看更多>
invasive disease-free survival 在 Evolution of invasive disease-free (IDFS) and overall survival ... 的相關結果
Nonmetastatic inflammatory breast cancer: Evolution of invasive disease-free (IDFS) and overall survival (OS) over a 21-year period. ... <看更多>
invasive disease-free survival 在 Checkmate 274 - Petros Grivas - UroToday 的相關結果
Adjuvant Therapy for Improved Disease-Free Survival for Patients with Muscle-Invasive Urothelial Carcinoma Following Radical Surgery - Checkmate ... ... <看更多>
invasive disease-free survival 在 IDFS（肿瘤学术语）_百度百科 的相關結果
iDFS源于DFS（disease-free survival，无病生存率），指乳腺癌治疗后无浸润性癌复发率。这一概念的提出是为了区分原位癌 。 参考资料. ... <看更多>
invasive disease-free survival 在 Are the classic factors predicting overall and disease-free ... 的相關結果
Are the classic factors predicting overall and disease-free survival after surgery for invasive bladder cancer? Bernardino. ... <看更多>
invasive disease-free survival 在 TARGIT-A randomised clinical trial | The BMJ 的相關結果
The other important outcomes were invasive local recurrence-free survival, mastectomy-free survival, distant disease-free survival, ... ... <看更多>
invasive disease-free survival 在 ICTRP Search Portal - WHO | World Health Organization 的相關結果
Patients with synchronous bilateral invasive disease are eligible ... specimen must be histologically free of invasive tumor and ductal ... ... <看更多>
invasive disease-free survival 在 Genetic test identifies patients with invasive lobular breast ... 的相關結果
ILC accounts for about 10% of cases of invasive breast cancer. ... patients surviving without the disease recurring (disease-free survival, ... ... <看更多>
invasive disease-free survival 在 2020 San Antonio Breast Cancer Symposium 的相關結果
Ipsilateral breast tumor recurrence (IBTR)-free survival and distant ... in the risk of developing invasive disease with abemaciclib plus ET ... ... <看更多>
invasive disease-free survival 在 Postneoadjuvant T-DM1 + tucatinib/placebo in patients with ... 的相關結果
... in patients with residual HER2-positive invasive breast cancer ... if the invasive disease-free survival (iDFS) with T-DM1 plus tucatinib is superior to ... ... <看更多>
invasive disease-free survival 在 a3947p - SEC.gov 的相關結果
IDMC has concluded that OlympiA trial of Lynparza crossed superiority boundary for invasive disease-free survival vs. placebo at planned ... ... <看更多>
invasive disease-free survival 在 Neratinib Improves Two-Year Survival in Breast Cancer After ... 的相關結果
At 2 years, the invasive disease-free survival rate was 93.9% in the neratinib arm and 91.6% in the placebo arm (HR=0.67; 95% CI: 0.50, 0.91; P= ... ... <看更多>
invasive disease-free survival 在 HER2low invasive breast cancer: Trastuzumab offers no ... 的相關結果
Ultimately, trial findings were negative, with trastuzumab offering no improvement for invasive disease free survival. Watch the press conference for more. ... <看更多>
invasive disease-free survival 在 jRCT2061200033 - ｜NIPH Clinical Trials Search - 国立保健 ... 的相關結果
T-DM1 in high-risk HER2-positive patients with residual invasive breast cancer ... Primary Outcome, Invasive Disease-free Survival (IDFS) in ... ... <看更多>
invasive disease-free survival 在 Article "Nothing is permanent except for change: Disease-free ... 的相關結果
Article "Nothing is permanent except for change: Disease-free survival in cancer, time to change?" is published under. Year: 2021 Volume: 17 Issue: 4 ... <看更多>
invasive disease-free survival 在 More Breast Cancer Patients Can Safely Skip Chemotherapy 的相關結果
Most women in the mid-range can avoid chemo · Five years after treatment, the rate of invasive disease-free survival was 93.1% for those who had ... ... <看更多>
invasive disease-free survival 在 Primary outcome analysis of invasive disease-free survival for ... 的相關結果
Primary outcome analysis of invasive disease-free survival for monarchE a Quebec perspective. Interview with Dr Rami J. Younan. Watch Now. ... <看更多>
invasive disease-free survival 在 Ingrid Mayer, MD, on the Disappointing Results of the EA1131 ... 的相關結果
... not extend invasive disease-free survival compared with capecitabine ... with TNBC residual disease following neoadjuvant chemotherapy, ... ... <看更多>
invasive disease-free survival 在 Adjuvant Chemotherapy Guided by a 21-Gene Expression ... 的相關結果
Endocrine therapy was noninferior to chemoendocrine therapy in the analysis of invasive disease–free survival (hazard ratio for invasive disease ... ... <看更多>
invasive disease-free survival 在 KATHERINE Trial: Trastuzumab Emtansine Reduces Risk of ... 的相關結果
All patients had residual invasive disease in the breast or axillary ... Secondary efficacy endpoints of disease-free survival and distant ... ... <看更多>
invasive disease-free survival 在 Post-lumpectomy Breast Radiation lowers iBR for “Good Risk ... 的相關結果
reduced all and invasive ipsilateral breast recurrence ... disease-free survival, distant metastasis, subsequent mastectomy, and toxicity. ... <看更多>
invasive disease-free survival 在 Lymph Node Involvement in Early-Stage Cervical Cancer - MDPI 的相關結果
disease -free survival and recurrence; irrespective of nodal status, ... As a positive control, we used an invasive breast carcinoma specimen. ... <看更多>
invasive disease-free survival 在 Combination of tucatinib and neural stem cells secreting anti ... 的相關結果
In combination with trastuzumab, pertuzumab further improves invasive disease-free survival among patients with HER2+ breast cancer (17). ... <看更多>
invasive disease-free survival 在 Neighborhood Socioeconomic Disadvantage Associated with ... 的相關結果
Major complications, mortality and survival outcomes were compared ... demonstrated worse overall survival and recurrence free survival than ... ... <看更多>
invasive disease-free survival 在 Pten and other ptdins(3,4,5)p3 lipid phosphatases in breast ... 的相關結果
... with triple negative breast cancers and reduced relapse-free and overall survival. ... which correlates with invasive disease and reduced survival. ... <看更多>
invasive disease-free survival 在 Disease-Free Survival DFS in Cancer Treatments - Verywell ... 的相關結果
Disease -free survival (DFS) is a very commonly used term used to describe the results of cancer treatments. Learn what it means. ... <看更多>
invasive disease-free survival 在 Upper tract urothelial carcinoma - Renal and Urology News 的相關結果
Nivolumab treatment for patients who have undergone radical surgery for high-risk muscle-invasive urothelial carcinoma improves their disease-free survival ... ... <看更多>
invasive disease-free survival 在 Mesothelioma Survival Rates & Statistics by Age, Gender ... 的相關結果
Learn about average cancer survival rates by age, race, stage & type of ... Tumor Location; Stage of disease; Mesothelioma cell type ... ... <看更多>
invasive disease-free survival 在 Pancreatic cancer - Symptoms and causes - Mayo Clinic 的相關結果
Signs and symptoms of pancreatic cancer often don't occur until the disease is advanced. They may include: Abdominal pain that radiates to your ... ... <看更多>
invasive disease-free survival 在 Definition of disease-free survival - NCI Dictionary of Cancer ... 的相關結果
disease -free survival ... In cancer, the length of time after primary treatment for a cancer ends that the patient survives without any signs or symptoms of that ... ... <看更多>